Amniotics: Orphan Drug Designation for PulmoStem

Research Note

2023-11-21

08:20

Redeye has a positive view of PulmoStem obtaining orphan drug designation for lung transplantation from the EMA, which we discuss briefly.

RR

Richard Ramanius

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.